PLC
Principal U.S. Large-Cap Multi-Factor ETF
Set alert
30.13 USD 0.00 0.00%
30.05 Day range 30.21
18.95 52-week range 30.49
- Open
- 30.21
- Prev close
- 30.13
- Mkt cap
- 7.44M
- Vol
- 677
- Avg vol
- 227
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 30.05
- High
- 30.21
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 30.13
- 200-d avg
- 28.40
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 30.13
- 200-day average
- 28.40
About Principal U.S. Large-Cap Multi-Factor ETF
The investment seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq US Large Cap Select Leaders Core Index. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of U.S. companies with large market capitalizations that compose the index at the time of purchase. The index uses a quantitative model designed to identify equity securities of companies in the Nasdaq US Large Cap Index that exhibit potential for high degrees of value, quality growth and strong momentum.
News
- Davion Healthcare PLC Agrees $13.5 Million Acquisition of Profitable US Home Healthcare Business
- SHELL PLC 2027 INTERIM DIVIDEND TIMETABLE
- SHELL PLC 3rd QUARTER 2026 AND NINE MONTHS UNAUDITED RESULTS
- Georgia Capital PLC (GRGCF) Q3 2026 Earnings Call Transcript
- Standard Chartered PLC (SCBFY) Q3 2026 Earnings Call Transcript
- AstraZeneca, Amgen Score Phase 3 Win in Debilitating Swallowing Disease
Your note
Sign in to keep a note on PLC — it syncs with the Stock Master app.